Frontiers

Traditional Therapies for Autoimmune and Allergic Diseases: Evidence Mapping and Mechanisms

Autoimmune and allergic diseases are complex, multifaceted conditions that continue to challenge clinicians and researchers worldwide. Standard ...
The Lancet

A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA

qCenter for Infection and Immunity, Yale University School of Medicine, New Haven, CT, USA rCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA sSection of ...
STAT

FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. John Wilkerson is a Washington ...
Everyday Health

Switching Medications: What to Do if Crohn’s Disease Treatment Isn’t Working

It’s possible to achieve remission if you have Crohn’s disease, but it isn’t always easy to find a treatment that will help you get there. Many people with inflammatory bowel disease (IBD) switch ...
NPR

The FDA creates a quicker path for gene therapies

The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new ...
spectrumlocalnews

FDA says it will speed up rare disease treatment approvals

WASHINGTON — The U.S. Food and Drug Administration announced a new strategy on Monday to speed up treatments for rare diseases. Called the plausible mechanism framework, the draft FDA guidelines ...
CNBC

FDA proposes new system for approving customized drugs and therapies for rare diseases

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...
The Hill

FDA proposes new treatment approval pathway for ultrarare diseases

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...